Dentamet (Gel) Instructions for Use
Marketing Authorization Holder
Altayvitamins, JSC (Russia)
ATC Code
A01AB11 (Other drugs)
Active Substances
Metronidazole (Rec.INN registered by WHO)
Chlorhexidine (Rec.INN registered by WHO)
Dosage Form
| Dentamet | Dental gel 10 mg/1 g+1 mg/1 g: tubes 10 g or 25 g |
Dosage Form, Packaging, and Composition
Dental gel from white to white with a yellowish tint, homogeneous.
| 1 g | |
| Metronidazole | 10 mg |
| Chlorhexidine (in the form of a 20% bigluconate solution) | 5 mg, |
| Equivalent to the content of chlorhexidine (in the form of bigluconate) | 1 mg |
Excipients: levomenthol (L-menthol), glycerol (glycerin), propylene glycol, trolamine (thermostable triethanolamine), carbomer, sodium saccharin dihydrate, purified water.
10 g – aluminum tubes (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug with antimicrobial action for topical use in dentistry
Pharmacotherapeutic Group
Drugs used in dentistry; antimicrobial drugs and antiseptics for the local treatment of oral diseases
Pharmacological Action
Combined antimicrobial drug for topical application.
Metronidazole is a nitroimidazole derivative with antiprotozoal and antibacterial action against anaerobic protozoa and anaerobic bacteria causing periodontitis: Porphyromonas gingivalis, Prevotella intermedia, Prevotella denticola, Fusobacterium fusiformis, Wolinella recta, Treponema spp., Eikenella corrodens, Borrelia vincenti, Bacteroides melaninogenicus, Selenomonas spp.
It is inactive against aerobic bacteria.
The mechanism of action involves the biochemical reduction of the 5-nitro group of metronidazole by intracellular transport proteins of anaerobic microorganisms and protozoa. The reduced 5-nitro group of metronidazole interacts with the DNA of the microorganism cell, inhibiting the synthesis of their nucleic acids, which leads to bacterial death.
Chlorhexidine is a disinfectant active against a wide range of vegetative forms of gram-negative and gram-positive microorganisms, yeasts, dermatophytes, and lipophilic viruses. It acts on bacterial spores only at elevated temperatures. The bactericidal effect is due to the binding of cations (a result of the dissociation of the chlorhexidine salt in a physiological environment) with the negatively charged walls of bacterial cells and extramicrobial complexes. In low concentrations, by disrupting the osmotic balance of bacterial cells and the release of potassium and phosphorus ions from them, it has a bacteriostatic effect; in high concentrations, the cytoplasmic content of the bacterial cell precipitates, ultimately leading to bacterial death.
Indications
Acute gingivitis; acute necrotizing ulcerative Vincent’s gingivitis; chronic edematous gingivitis; chronic hyperplastic gingivitis; chronic atrophic (desquamative) gingivitis; chronic periodontitis; periodontal abscess; recurrent aphthous (ulcerative) stomatitis; gangrenous pulpitis; post-extraction alveolitis; juvenile periodontitis; toothache of infectious origin.
ICD codes
| ICD-10 code | Indication |
| A69.1 | Other Vincent's infections |
| K04 | Diseases of pulp and periapical tissues (including periodontitis) |
| K05 | Gingivitis and periodontal diseases |
| K08.8 | Other specified disorders of teeth and supporting structures (including toothache) |
| K10.3 | Alveolitis of jaws |
| K12 | Stomatitis and related lesions |
| ICD-11 code | Indication |
| 1C4Z | Unspecified bacterial disease |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA06.1 | Alveolitis of jaw |
| DA09.Z | Diseases of pulp and periapical tissues, unspecified |
| DA0A.Z | Diseases of teeth and supporting structures, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
| LA30.5Z | Anomalies of tooth resorption or loss, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For dental use only.
Apply the gel topically after thorough teeth brushing.
Dry the affected gum area with a gauze pad before application.
Apply a thin layer of gel directly to the gingival margin and interdental spaces.
Use the gel twice daily, typically in the morning and evening.
Refrain from eating or drinking for at least 30 minutes after application.
For preventive purposes, mix a small amount of gel with your toothpaste.
The standard treatment course is 7 to 10 days.
Do not exceed the recommended duration of use without consulting a dentist.
If symptoms persist after a full course, seek professional dental advice.
Adverse Reactions
Local reactions: “metallic” taste in the mouth.
Systemic reactions: headache, allergic reactions (skin rash, itching, urticaria).
Contraindications
Hypersensitivity (including to metronidazole, chlorhexidine, and nitroimidazole derivatives); children under 18 years of age (depending on the drug form used).
Use in Pregnancy and Lactation
Use during pregnancy is not recommended.
If use during lactation is necessary, the issue of discontinuing breastfeeding should be considered.
Pediatric Use
Contraindication – children under 18 years of age.
Special Precautions
The use of the drug does not replace hygienic teeth cleaning, so during the course of treatment with the drug, teeth brushing should be continued. However, the application of the gel should not be combined simultaneously with toothpaste.
Avoid contact with eyes.
Drug Interactions
It enhances the anticoagulant effect of warfarin (increased prothrombin formation time).
Concomitant use with disulfiram increases toxicity, which may lead to the development of neurological symptoms.
The antimicrobial activity of metronidazole is reduced with simultaneous use of phenobarbital and phenytoin due to accelerated metabolism of metronidazole.
Cimetidine inhibits the metabolism of metronidazole, which may lead to an increase in the concentration of metronidazole in the blood serum.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer